Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

There is a new treatment for patients with relapsing multiple sclerosis (MS) and primary progressive MS. The US Food and Drug Administration (FDA) announced the approval of Ocrevus (ocrelizumab, Genentech). This intravenous infusion is the first new treatment for primary progressive MS, according to a press release from the FDA.
Interviews with Justine Naylor, PhD, and Andrew Fleischman, MD
Draft guidelines to improve transparency at the FDA are released.
Cone snail venom shows promise in early animals studies as a treatment for chemotherapy-induced neuropathies.
Physicians and chronic pain patients react to the proposed Republican repeal of the Affordable Care Act.
Exercise plans that are tailored to the individual, to be conducted at home, reduce pain and enhances recovery in patients being treated for cancer.
Researchers used fMRI to map pain responses in people with fibromyalgia to shed light on the neurophysiology of this condition.
Low intensity pulsed ultrasound (LIPUS) fails to promote bone-healing, or offer beneficial effects on function or pain relief.
Psoriasis patients diagnosed with major depressive disorder appear at increased risk for psoriatic arthritis (PsA).
Rapid access to physical therapy may improve outcomes for patients with acute back pain.
Quadriceps strength may be useful in predicting loss of function in people with or at risk for knee osteoarthritis.
The American College of Physicians' new guidelines make a strong case for the use of nonpharmacological therapies as a first-line option for treating nonspecific low back pain in patients.
In patients with a traumatic spinal cord injury (SCI), researchers identified characteristics that may guide who is most likely to misuse pain medications.
A new study has examined what role pain catastrophizing behaviors could have on the functional outcomes of patients living with chronic pain and has found age could be a significant factor.
Evaluating oral fluid samples revealed that hydrocodone is an important metabolite of codeine, which may be useful in monitoring medication use by pain patients and for drug testing.